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Detection of free radicals in tissues is challenging. Most approaches rely on incubating excised sections or homogenates with
reagents, typically at supraphysiologic oxygen tensions, to finally detect surrogate, nonspecific end products. In the present
work, we explored the potential of using intravenously (i.v.) injected dihydroethidine (DHE) to detect superoxide radical
(O2
∙-) abundance in vivo by quantification of the superoxide-specific DHE oxidation product, 2-hydroxyethidium (2-OH-E+),
as well as ethidium (E+) and DHE in multiple tissues in a murine model of endotoxemia induced by lipopolysaccharide (LPS).
LPS was injected intraperitoneally (i.p.), while DHE was delivered via the tail vein one hour before sacrifice. Tissues (kidney, lung,
liver, and brain) were harvested and subjected to HPLC/fluorescent analysis of DHE and its monomeric oxidation products. In
parallel, electron spin resonance (EPR) spin trapping was used to measure nitric oxide (∙NO) production in the aorta, lung, and
liver isolated from the same mice. Endotoxemic inflammation was validated by analysis of plasma biomarkers. The concentration
of 2-OH-E+ varied in the liver, lung, and kidney; however, the ratios of 2-OH-E+/E+ and 2-OH-E+/DHE were increased in the
liver and kidney but not in the lung or the brain. An LPS-induced robust level of ∙NO burst was observed in the liver, whereas the
lung demonstrated a moderate yet progressive increase in the rate of ∙NO production. Interestingly, endothelial dysfunction was
observed in the aorta, as evidenced by decreased ∙NO production 6 hours post-LPS injection that coincided with the inflammatory
burden of endotoxemia (e.g. elevated serum amyloid A and prostaglandin E2). Combined, these data demonstrate that systemic
delivery of DHE affords the capacity to specifically detect O2
∙- production in vivo. Furthermore, the ratio of 2-OH-E+/E+
oxidation products in tissues provides a tool for comparative insight into the oxidative environments in various organs. Based on
our findings, we demonstrate that the endotoxemic liver is susceptible to both O2
∙--mediated and nonspecific oxidant stress as
well as nitrosative stress. Oxidant stress in the lung was detected to a lesser extent, thus underscoring a differential response of
liver and lung to endotoxemic injury induced by intraperitoneal LPS injection.
1. Introduction
Reactive oxygen species (ROS) are critical components of var-
ious disease processes with superoxide anion radical (O2
∙-)
often assuming the center of attention. Due to the high reac-
tivity of both ROS and reactive nitrogen species (RNS), most
methods rely on the ex vivo quantification of stable end prod-
ucts or steady-state intermediates in tissues or biological
fluids. Dihydroethidine (DHE) oxidation to superoxide-
specific 2-hydroxyethidium (2-OH-E+), detected with high-
performance liquid chromatography (HPLC), is regarded as
the most specific and sensitive quantitative method alterna-
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tive to electron paramagnetic resonance (EPR) for measuring
O2
∙- to date [1]. Typically, excised tissues or cells are incubated
ex vivowith DHE [2, 3]. Nevertheless, there have been studies
describing the topical administration of DHE to murine
carotid arteries [4], where DHE was applied in vivo intraperi-
toneally [5–11] or intravascularly [12, 13] to study oxidative
stress ex vivo in the brain usingDHE-derived red fluorescence
as amarker ofO2
∙- production; unfortunately, this is not a spe-
cific method of O2
∙- detection [14]. Moreover, subcutaneous
injection ofDHEhas been used to studyO2
∙- in various tissues
with fluorimetric detection [15, 16]; however, the authors did
not take into account that the major fluorescent product of
DHE oxidation is ethidium (E+) nor did they elucidate the
abundance of the parent compound in analyzed tissues.
The aim of this study was to assess the feasibility of multi-
organ in vivo oxidative stress detection using intravenously
injected DHE, with subsequent quantitative HPLC-based
analysis of the tissue accumulation of DHE, 2-OH-E+, and
E+ and their ratios. To evaluate this methodology, we used
mice with lipopolysaccharide- (LPS-) induced endotoxemia,
as this model is well characterized by an inflammatory reac-
tion with an NADPH-oxidase-dependent oxidant burst and
elevation in RNS through the inducible nitric oxide synthase
(NOS-2) pathway [17]. The LPS insult is known to increase
the level of proinflammatory cytokines [18, 19], which leads
to excessive production of nitric oxide (∙NO) via NOS-2 and
increased production of prostanoids due to cyclooxygenase-
2 (COX-2) induction aswell as concomitant alternativemech-
anisms leading to endotoxemic multiorgan failure [20]. Since
little is known regarding tissue-specific differences in changes
of ROS/RNS balance in vivo asmost studies focused on a single
target organ or analysis of proinflammatory cytokines [19, 20],
the tissue- and time-dependent changes in DHE oxidation
products were supplemented by ex vivo detection of ∙NO pro-
duction using EPR spin trapping in the isolated aorta, lung,
and liver tissues. Additional analysis from the blood was used
to validate endotoxemia severity for reliable interpretation.
2. Materials and Methods
2.1. Animal Experimental Protocol. Thirty male 3-month-old
C57Bl/6 mice purchased from Lodz University (Poland) were
randomly assigned into three experimental groups (control,
LPS 6h, and LPS 12 h), housed 5 per cage, and maintained
at 22-24°C under a 12-hour light/day cycle with ad libitum
access to water and rodent chow. To induce endotoxemia,
LPS (from Salmonella typhosa, Sigma-Aldrich, St. Louis,
MO, United States) was injected intraperitoneally (10mg/kg)
and mice were sacrificed six (n = 10) or twelve (n = 10) hours
later. Control animals (n = 10) were treated with intraperito-
neal injections of adequate volumes of saline six hours before
sacrifice. All mice received an injection of DHE (10mg/kg,
3mg/mL, 40% DMSO in PBS, in a roughly 90μL injection)
through the tail vein one hour before anesthetization with
ketamine and xylazine (100mg/kg and 10mg/kg, respec-
tively, i.p. Pfizer, New York, NY, United States). At the time
of sacrifice, the mouse chest was surgically opened, blood
was taken from the right ventricle into syringes containing
heparin (10U/mL), and animals were perfused via the left
and right ventricles with ice-cold PBS for a total of 10
minutes. Due to the light sensitivity of DHE [21], intravenous
injections as well as blood collection and tissue harvest were
conducted under low-light conditions. All experimental pro-
cedures were compliant with the Guide for the Care and Use
of Laboratory Animals published by the U.S. National Insti-
tutes of Health (NIH Publication No. 85-23, revised 1996)
and were approved by the First Local Ethical Committee
on Animal Experiments at the Jagiellonian University in
Krakow, Poland (permit no: 19/2016), in accordance with
the Guidelines for Animal Care and Treatment of the Euro-
pean Community.
2.2. HPLC-Based Detection of DHE and Oxidation Products
Formed In Vivo in Tissues. Immediately after perfusion, tis-
sues (lung, liver, kidney, and brain) were dissected, drained
on a piece of Kimwipe, snap-frozen in liquid nitrogen in
light-safe tubes, and stored at -80°C until analyzed. On the
day of HPLC analysis, the samples were thawed on ice and
homogenized, and DHE along with the oxidation products
were extracted and analyzed, as described previously [1] with
minor modifications [22]. Results were normalized to the
protein content of each sample, assessed in the initial super-
natant, unless stated otherwise.
2.3. Nitric Oxide Production Assessed Ex Vivo Based on EPR
Spin Trapping. Isolated aorta, liver, and lung tissues were
used for the measurement of ∙NO production by EPR spin
trapping with diethyldithiocarbamic acid sodium salt
(DETC) as described previously [23] with minor modifica-
tions. Briefly, endothelial nitric oxide synthase- (NOS-3-)
dependent production of ∙NO was measured by incubating
isolated and cleaned aortic tissue (n = 5 per group) with
350μl Fe(DETC)2 colloid (final concentration 285μM) with
the addition of calcium ionophore A23187 stimulation (final
concentration 1μM). Isolated lung lobe and liver pieces were
incubated similarly but without stimulation, to measure the
NOS-2-dependent nitric oxide production. After 90min of
incubation, each tissue was removed from the buffer, drained
on a piece of Kimwipe for 5 s, and its wet mass measured.
Measurement of the NO-Fe(DETC)2 signal in the frozen
samples was performed in a finger Dewar (Noxygen Science
Transfer & Diagnostics GmbH, Germany) using an EMX
Plus Bruker spectrometer (Bruker BioSpin GmbH, Silber-
streifen, Rheinstetten, Germany) with the following settings:
microwave power, 10mW; modulation amplitude, 0.8mT;
scan width, 11.5mT; scan time, 61.44 s; and number of scans,
4. The resulting spectra were collected and analyzed with
WinEPR Processing software (Bruker BioSpin GmbH).
The NO-Fe(DETC)2 signal was a clear triplet centered at
g = 2 039 and was quantified as the amplitude normalized
to the weight of tissue.
2.4. Quantification of Select Eicosanoids in Plasma. The quan-
tification of prostaglandin E2 and D2 (PGE2 and PGD2),
thromboxane B2 (TXB2), and 12-hydroxyeicosatetraenoic
acid (12-HETE) was performed using the liquid chromato-
graph UFLC Nexera (Shimadzu, Kyoto, Japan) coupled to
the triple quadrupole mass spectrometer QTRAP 5500
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(SCIEX, Framingham, MA, USA). Samples were purified via
a liquid-liquid extraction technique using 0.5mL of ethyl ace-
tate acidified with 0.13% of AA (v/v). After 10 minutes of
shaking (1500 rpm), 0.45mL of the organic layer was evapo-
rated to dryness under a nitrogen stream at 37°C. The dry
residue was reconstituted in 50μL EtOH, and samples were
injected onto an ACQUITY UPLC BEH C18 analytical col-
umn (3 0 × 100 mm, 1.7μm; Waters, Milford, MA, USA).
The mobile phase consisted of 0.1%FA in ACN (a) and
0.1%FA in water (v/v) (b), which was delivered at the flow
rate of 350μL/min. The detection of PGE2, PGD2, TXB2,
and 12-HETE as well as their internal standards was carried
out by applying negative ion electrospray ionization mass
spectrometry in the multiple reaction monitoring mode
(MRM). Data acquisition was performed under the following
optimized conditions: spray voltage: -4500V, source temper-
ature: 500°C, curtain gas: 25 psi, ion source gas 1: 40 psi, and
ion source gas 2: 50 psi.
2.5. Measurement of Plasma Xanthine Oxidase Activity. The
enzymatic activity of xanthine oxidase (XO) in plasma was
determined either spectrophotometrically by the rate of uric
acid formation monitored at 292nm in 50mM potassium
phosphate (KPi), pH7.4 (ε = 11mM−1 cm−1) or electrochem-
ically via reverse phase HPLC analysis of uric acid production
(ESA CoulArray System, Chelmsford, MA) (1Unit = 1μmole
urate/min) as described previously [24].
2.6. Biochemical Assays. Blood cell count was determined by
the hematology analyzer ABC Vet (Horiba, Germany).
Plasma obtained by centrifugation at 1000×g for 5min at
4°C was transferred into Protein LoBind tubes, split into
50μL aliquots, and stored at −80°C until further use. Alanine
aminotransferase (ALT), aspartate aminotransferase (AST),
and creatinine were measured using Pentra 400 (Horiba,
Kyoto, Japan), according to the manufacturer’s instructions.
Systemic nitric oxide production was characterized by nitrite
(NO2
−) and nitrate (NO3
−) concentrations in plasma using
the ENO-20 NOx Analyzer (Eicom Corp., Kyoto, Japan) as
described previously [25]. Mouse serum amyloid A (SAA)
was measured in heparinized plasma using an enzyme-
linked immunosorbent assay kit (Phase SAA Murine Assay
Kit, cat. No. TP-802M, Tridelta Development Ltd.), accord-
ing to the manufacturer’s protocol.
2.7. Statistical Analysis. Data are expressed as mean and SD
or median and interquartile ranges (Q1-Q3, IQR), depending
on data distribution and homogeneity of variance, tested
with Shapiro-Wilk’s and Bartlett’s or F tests. The significance
of differences was tested using one-way ANOVA or the
Kruskal-Wallis nonparametric test with appropriate post
hoc multiple comparison tests using GraphPad Prism 7
(GraphPad Software Inc., CA, USA). p values <0.05 were
considered statistically significant.
3. Results
3.1. Tissue-Specific In Vivo Oxidative Stress in Endotoxemia.
Using HPLC with fluorescent detection, the accumulation
of DHE injected via the tail vein and its superoxide-specific
and nonspecific oxidation products (2-OH-E+ and E+,
respectively) was quantified in the liver, lung, kidney, and
brain tissues (Table 1) in LPS-injected and control mice.
The parent DHE compound was detected in the liver and
lung tissue of control mice in similar amounts but was below
the limit of detection (LOD) in both kidney and brain. After
the LPS challenge, the DHE delivery to the liver was unaf-
fected; however, there was increased accumulation in the
lungs, which was statistically significant at 6 hours post-
injection. To compare tissues independently from their phar-
macokinetic profile, the ratio of 2-OH-E+/E+ was calculated
for each sample. In the liver, elevation of the 2-OH-E+ level
was observed (Figure 1(a)), indicating increased O2
∙--specific
oxidation 12h after LPS challenge, whereas E+ content
remained unchanged (Figure 1(d)). The 2-OH-E+/E+ ratio
confirmed superoxide-dependent oxidative stress in the liver
Table 1: DHE, 2-OH-E+, and E+ detected in tissues after injection of DHE (i.v.) in a murine model of endotoxemia, 6 and 12 hours after
LPS challenge.
Tissue Control LPS 6 h LPS 12 h
DHE (pg/mg protein)
Liver 104 ± 70 (n = 6) 81 ± 72 (n = 9) 60 ± 15 (n = 6)
Lung 139 ± 51 (n = 4) 920 ± 501 (n = 7)∗ 782 ± 566 (n = 4)
Kidney <LOD <LOD <LOD
Brain <LOD <LOD <LOD
2-OH-E+ (pg/mg protein)
Liver 0 26 ± 0 18 (n = 6) 0 19 ± 0 15 (n = 8) 1 18 ± 0 80 (n = 9)∗
Lung 21 1 ± 2 6 (n = 4) 42 8 ± 8 6 (n = 7)∗∗ 38 7 ± 17 4 (n = 4)∗
Kidney 0 56 ± 0 41 (n = 8) 0 34 ± 0 26 (n = 9) 0 55 ± 0 23 (n = 9)
Brain < LOD 0 12 ± 0 04 (n = 3) 0.31 (n = 1)
E+ (pg/mg protein)
Liver 7 9 ± 5 7 (n = 6) 7 0 ± 4 7 (n = 8) 12 1 ± 3 9 (n = 7)
Lung 85 ± 14 (n = 4) 227 ± 63 (n = 7)∗∗ 221 ± 62 (n = 4)∗
Kidney 17 3 ± 8 5 (n = 8) 6 8 ± 5 8 (n = 9)∗ 13 1 ± 6 7 (n = 10)
Brain 16 1 ± 8 8 (n = 7) 7 6 ± 5 3 (n = 7)∗∗ 12 9 ± 7 6 (n = 8)∗
Data are presented as mean ± SD. Results of Student’st-test vs. control (in bold):∗p < 0 05, ∗∗p < 0 01, ∗∗∗p < 0 005, and ∗∗∗∗p < 0 001.
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12 h after LPS challenge (Figure 1(g)). In the lung, there were
increases in both 2-OH-E+ and E+ concentrations 6 h and
12 h post-LPS injection (Figure 1(b) and 1(e), respectively).
In turn, there was no statistical difference in the 2-OH-
E+/E+ ratio (Figure 1(h)). In the kidney, 2-OH-E+ and E+
concentrations were unchanged (Figure 1(c) and 1(f), respec-
tively); however, a gradual increase in the 2-OH-E+/E+ ratio
was appreciated (Figure 1(i)), which attained statistical sig-
nificance 12 h post-LPS injection. In the brain, there was no
2-OH-E+ found in any of the samples from the control group
and only a few samples were above the limit of detection in
LPS-injected mice (3 among 10 for the 6 h group and 1
among 10 for the 12 h group); however, E+ was detected in
all samples. The 2-OH-E+/E+ ratio was unchanged between
control and LPS-treated mice. Where applicable (liver and
lung), the ratios of 2-OH-E+/DHE and E+/DHE were also
calculated to quantify the amount of oxidation products in
relation to DHE deposition in particular samples (Figure 2).
3.2. Tissue-Specific Ex Vivo Nitric Oxide Production and
Plasma Nitrate/Nitrite Concentration in Endotoxemia. In
the aorta, decreased ionophore-stimulated ∙NO production
was detected (Figure 3(a)) post-LPS, which was compatible
with impaired NOS-3-dependent nitric oxide production
and endothelial dysfunction. A moderate and progressive
increase in ∙NO production was detected in the lung
(Figure 3(b)), while a strong nitric oxide burst was noted in
the liver (Figure 3(c)), compatible with the differential extent
of NOS-2 induction in the liver as compared with the lung.
Likewise, nitrite and nitrate (Figures 3(d) and 3(e)) levels
were both progressively elevated compared to those of the
control mice; however, a statistically significant difference
between 6 and 12 hours after LPS administration was found
only for nitrate.
3.3. Biochemical Markers in Plasma and Blood Count
Changes in Endotoxemia. The development of endotoxemic
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Figure 1: Monomeric DHE oxidation products formed in vivo in the liver (a, d, and g), lung (b, e, and h), and kidney (c, f, and i) tissues in a
murine model of endotoxemia, 6 and 12 hours after LPS challenge. Using HPLC-Fl detection, the superoxide-specific 2-OH-E+ and
nonspecific E+ monomeric products of DHE oxidation were measured according to the details presented in Materials and Methods.
Additionally, the ratio of 2-OH-E+/E+ was calculated for each sample. Data are presented as mean ± SD or median ± IQR, and statistical
significance was tested using one-way ANOVA or the nonparametric Kruskal-Wallis ANOVA, depending on the distribution and
homoscedasticity of data. p values <0.05 were considered significant, with ∗ <0.05 and ∗∗ <0.01 versus the control group and ○○ <0.01
versus the LPS 6 h group.
4 Oxidative Medicine and Cellular Longevity
inflammation after injection of LPS was confirmed by dra-
matically increased SAA, 6 h after LPS injection that further
increased 12h after LPS challenge and was associated with
a significant increase in plasma biomarkers of liver (ALT,
AST) and kidney (creatinine) injuries (Figure 4) as well as
blood count changes (Table 2). The LPS-induced changes
in the eicosanoid profile (Figure 5) encompassed elevation
of plasma concentration of PGE2, without changes in
PGD2, but increased TXB2 and 12-HETE concentration in
plasma. Furthermore, an approximately 5-fold significant
(p < 0 0007, Kruskal-Wallis ANOVA, post hoc Dunn’s test)
and sustained increase in plasma xanthine oxidoreductase
activity was found in LPS-challenged mice (6 h: 2.0, 1.3-2.7
and 12 h: 1.9, 1.4-2.8, in mU/mL) when compared with the
control group (0.4 and 0.2-0.6mU/mL).
4. Discussion
In the present work, taking advantage of the HPLC-based
methodology for the assessment of oxidative stress and
O2
∙- production in vivo, based on the quantification of
DHE uptake and monomeric oxidation product forma-
tion (2-hydroxyethidium (2-OH-E+) and ethidium (E+))
combined with ex vivo EPR spin trapping of nitric oxide
production, we demonstrated the differential progression
and heterogeneity of oxidative and nitrosative stress in endo-
toxemia in various organs. LPS-induced inflammation was
confirmed by several biomarkers [17] including blood count,
SAA, and eicosanoids (Table 2, Figures 4 and 5). It is impor-
tant to note that DHE was administered intravascularly to
overcome impaired splanchnic microcirculation in endotox-
emia, which could have disturbed the uptake of DHE via the
hepatic portal system following intraperitoneal injection of
DHE used previously [5–11, 26].
Results demonstrated variable distribution of DHE, with
the lung exhibiting the greatest uptake followed by the liver,
kidney, and brain. In the control group, the lung exhibited
a 100-fold greater accumulation of 2-OH-E+ and 5-10-fold
greater accumulation of E+ compared to the other three tis-
sues (Table 1), suggesting that the lung represents a major
target for DHE following i.v. injection. After LPS administra-
tion, the lung has shown a 6-7-fold increase in DHE accumu-
lation, most likely due to increased pulmonary vascular
permeability, as reported in acute lung injury [27]. Further-
more, there was roughly a 2-fold increase in both 2-OH-E+
and E+ detected in the lungs after LPS challenge. This alone
would suggest robust oxidative stress in the lung in endotox-
emia, and due to an unaltered 2-OH-E+/E+ ratio, one could
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Figure 2: Superoxide-specific and unspecific oxidation of DHE accumulated in the liver and lung tissue in a murine model of
endotoxemia, 6 and 12 hours after LPS challenge. Ratios of 2-OH-E+/DHE accumulated in the liver and lung tissues suggest that the
liver is under increased superoxide-specific oxidant stress (a), as opposed to the lung (b). Moreover, the ratio of E+/DHE also
suggests increased superoxide-independent oxidative stress in the liver (c), which is not the case in the lung (d). Data are presented as
median ± IQR, and statistical significance was tested using nonparametric Kruskal-Wallis ANOVA. p values <0.05 were considered
significant, with ∗<0.05 and ∗∗<0.01 versus the control group, and <0.01 versus the LPS 6 h group.
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speculate that both superoxide-dependent and superoxide-
independent mechanisms are responsible. However, with
DHE also measured and the 2-OH-E+/DHE ratio unchanged
along with reduced E+/DHE ratio (Figure 2(b) and 2(d),
respectively), this would rather suggest that during endotox-
emia in the lung, the single electron oxidation of DHE might
be shifted from disproportionation, which leads to E+ forma-
tion, towards dimerization, resulting in the formation of
dimeric products [14], though verification of this hypothesis
remains beyond the scope of this article. A different distribu-
tion pattern was observed in the liver where DHE, 2-OH-E+,
and E+ accumulation did not change upon LPS challenge,
despite a systemic increase in vascular permeability in
endotoxemia [28] and dysfunctional hepatic circulation
post-LPS injection. Nevertheless, the 2-OH-E+/E+ ratio
increased significantly 12 hours post-LPS challenge
(Figure 1(g)), similar to both 2-OH-E+/DHE and E+/DHE
ratios (Figure 2(a) and 2(c), respectively), suggesting that
the liver is under O2
∙--dependent and O2
∙--independent oxi-
dative stress. With no DHE detected in the brain and kid-
ney, the origin of the detected 2-OH-E+ and E+ remains
unclear. These could have accumulated from the circula-
tion, as the blood-brain barrier integrity after LPS is com-
promised [28]. Importantly, only E+ was found in the
brain tissue, suggesting that the previously reported oxida-
tive stress using DHE fluorescence in the brain [5–13]
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Figure 3: Nitric oxide production ex vivo in tissues and nitrite/nitrate burst in plasma in a murine model of endotoxemia, 6 and 12 hours
after LPS challenge. EPR spin trapping as described in Materials and Methods was used to detect nitric oxide ex vivo in the aorta, lung, and
liver tissues (a, b, and c, respectively), whereas nitrite (d) and nitrate (e) were measured in the plasma using the ENO-20 apparatus.
Gradually increased NO production was seen in the lungs at 6 and 12 hours post-LPS injection (b), while the liver showed a much
higher NO overproduction (c, 6-7-fold change). Data are presented as mean ± SD or median ± IQR (in c), and statistical significance
was tested using one-way ANOVA post hoc LSD’s test or Kruskal-Wallis’s, post hoc Dunn’s (in c), depending on the distribution and
homoscedasticity of data. p values < 0.05 were considered significant, with ∗ <0.05, ∗∗ <0.01, ∗∗∗ <0.005, and ∗∗∗∗ <0.001 versus the
control group.
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may not have been formed in situ. On the other hand, DHE
could have reached these tissues but was not detectable due
to complete oxidation.
Inhomogeneous DHE organ distribution and various
contents of oxygenation products in organs demonstrate
the value of our approach. This was based on the normaliza-
tion of 2-OH-E+ abundance to the amount of DHE accumu-
lated in the tissue or to the amount of E+ formed, assuming
E+ also reflects the intracellular uptake of DHE [29]. The lat-
ter approach has shown superoxide-driven oxidative stress in
the liver and kidney 12 hours after injection of LPS
(Figures 1(d), 1(g) and 1(f), 1(i), respectively) but not in
the lung (Figure 1(e) and 1(h)), questioning the reliability
of oxidative stress assessment based solely on 2-OH-E+ mea-
surements. In fact, after LPS the lung exhibited increased
deposition of DHE monomeric oxidation products as well
as the parent compound. Calculation of the ratio of 2-
OH-E+/DHE in the lung samples, unaffected by LPS
administration, suggests that the increase in 2-OH-E+ contents
is related to higher DHE accumulation after LPS (Figure 2(b)).
Interestingly, the ratio of E+/DHE (Figure 2(d)) significantly
decreased in the lungs of LPS-treated mice, suggesting that in
these conditions the dimeric products of DHE oxidation
might be favorable perhaps due to cytochrome c activity,
which is known to promote DHE oxidation to the dimeric
products over ethidine [14]. Alternatively, the lower ratio of
E+/DHE might be due to increased hydrogen peroxide
(H2O2) production in the lungs, which could oxidize cyto-
chrome c and thus generate cytochrome c redox cycling
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Figure 4: Markers of the organ injury and systemic inflammation in a murine model of endotoxemia, 6 and 12 hours after LPS challenge.
Liver damage—ALT (a) and AST (b), kidney damage—creatinine (c), and systemic inflammation—SAA (d). Data are presented as mean
± SD or median ± IQR, and statistical significance was tested using one-way ANOVA post hoc LSD’s test or Kruskal-Wallis, post hoc
Dunn’s, depending on the distribution and homoscedasticity of data. p values <0.05 were considered significant, with ∗ <0.05, ∗∗ <0.01,
and ∗∗∗∗ <0.001 versus the control group and ○ <0.05 and ○○ <0.01 versus the LPS 6 h group.
Table 2: Hematologic alterations in endotoxemia, 6 and 12 hours
after LPS challenge.
Control LPS 6 h LPS 12 h
WBC (103/μL) 8 51 ± 1 00 4 52±0 61∗∗∗ 7 69 ± 1 04#
RBC (103/μL) 10 26 ± 0 25 9 55 ± 0 15∗ 8 73±0 31∗∗∗ ,#
PLT (103/μL) 1145 ± 55 663±51∗∗∗∗ 642±51∗∗∗∗
GRA (%) 36 6 ± 2 8 50 3±2 3∗∗∗∗ 65 1±2 1∗∗∗∗ ,####
MON (%) 7 14 ± 0 28 10 29 ± 1 07∗ 8 66 ± 0 53∗
LYM (%) 56 3 ± 2 8 39 6±1 6∗∗∗∗ 25 9±1 8∗∗∗∗ ,####
GRA (103/μL) 3 27 ± 0 47 2 30 ± 0 26 5 03 ± 0 75
Hct (103/μL) 56 1 ± 1 4 52 9 ± 1 0 47 6±1 8∗∗∗ ,#
HGB (103/μL) 15 43 ± 0 28 14 68 ± 0 29 13 64±0 46∗∗∗
LYM (103/μL) 4 69 ± 0 54 1 97±0 31∗∗∗∗ 1 79±0 15∗∗∗∗
MCH (103/μL) 15 08 ± 0 25 15 37 ± 0 14 15 64 ± 0 21
MCHC (103/μL) 27 53 ± 0 28 27 76 ± 0 19 28 71±0 24∗∗ ,##
MCV (103/μL) 54 78 ± 0 57 55 30 ± 0 45 54 50 ± 0 67
MON (103/μL) 0 56 ± 0 08 0 61 ± 0 21 0 63 ± 0 12
MPV (103/μL) 5 37 ± 0 12 5 11 ± 0 05 5 50 ± 0 12##
RDW (103/μL) 12 2 ± 0 2 12 1 ± 0 2 12 3 ± 0 3
WBC—white blood cells, RBC—red blood cells, PLT—platelets,
GRA—granulocytes, MON—monocytes, and LYM—lymphocytes. Results
of Student’st-test vs. control:∗p < 0 05, ∗∗p < 0 01, ∗∗∗p < 0 005, and ∗∗∗∗
p < 0 001; LPS 6 h vs. 12 h:#p < 0 05, ##p < 0 01, and ####p < 0 001.
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[30], in consequence producing more superoxide and oxidiz-
ing DHE to 2-OH-E+ in favor of E+. Similar analysis for the
liver showed increased ratios of both 2-OH-E+/DHE and
E+/DHE twelve hours after LPS injection, suggesting that
both superoxide and other ROS contribute to oxidant stress
in the liver (Figure 2(a) and 2(c)), respectively. In fact, xan-
thine oxidoreductase (XOR) activity was increased in the
plasma of LPS-treated mice (6 h: 2.0, 1.3-2.7 and 12h: 1.9,
1.4-2.8, inmU/mLvs. 0.4, 0.2-0.6mU/mL in control), suggest-
ing that XOR-catalyzed H2O2 production, the major ROS
product of XOR under physiological and hypoxic O2 tensions
[31], might be relevant. However, dimeric DHE oxidation
products, notmeasured here due to technical limitations, have
also been associated with H2O2/heme protein reactions [32].
Higher levels of oxidation products detected after LPS
might be related to amplified DHE uptake caused by
increased permeability, as shown in LPS-induced acute lung
injury by [27] along with increased NO production in this tis-
sue (Figure 3(b)), rather than increased oxidative stress itself.
Another plausible explanation for increased E+ concentra-
tion in the lung and liver tissue is peroxynitrite (O=NOO-)
formation that occurs when both ∙NO and O2
∙- production
are increased. In fact, peroxynitrite formation and increased
protein nitration have previously been reported in the lung
and liver in LPS-challenged mice [33, 34]. Our methodology
for ∙NO detection in the lung and liver tissues did not use
exogenous stimuli; therefore, EPR spin trapping results
reflect the basal ∙NO production with a fairly low level of
∙NO production in the control group. However, after LPS
administration the level of ∙NO produced in the lung tissue
significantly increased at 6 h and even to a greater extent at
12 h post-injection. As shown in a rat model of lung inflam-
mation by [35], LPS induces NOS-2 but not NOS-3 or NOS-1
in the lung tissue, which upholds our conclusion. Neverthe-
less, the nitric oxide increase observed in the lung is rather
moderate compared to the effects LPS had on nitric oxide
production in the liver (Figure 3(c)), which can be
accounted to NOS-2 activation in hepatocytes as early as
3 h after LPS treatment of an isolated rat liver, as shown
in a previous work [36]. Furthermore, we saw increased
NOx-species in plasma (Figures 3(d) and 3(e)), altogether
suggesting systemic nitric oxide overproduction. In acute
inflammation and sepsis, this has been described previously
and was shown to provide protection in endotoxemia-
induced hepatic injury [37, 38] and initial protection against
acute oedema during the first two hours [39]. On the other
hand, oxidative/nitrosative stress linked to NOS-2 expres-
sion was shown to contribute to lung injury [40], while
all nitric oxide synthase isoforms contribute to acute perito-
nitis [41], showing evidence of organ- and time-dependent
∙NO-dependent protection. Based on our experiments, we
hypothesise that the high overproduction of ∙NO in the liver
after LPS injection provided protection from oxidative stress
6 hours after endotoxemia was initiated; however, at 12
hours post-LPS injection it leads to oxidative stress, which
is not only superoxide dependent. Interestingly, moderately
increased ∙NO production in the lung in endotoxemia corre-
lates with increased accumulation of DHE and its oxidation
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Figure 5: Eicosanoid concentration in plasma in a murine model of endotoxemia, 6 and 12 hours after LPS challenge. PGE2 (a), TXB2 (b), and
12-HETE (c). Data are presented as mean ± SD or median ± IQR, and statistical significance was tested using one-way ANOVA post hoc
LSD’s test or Kruskal-Wallis, post hoc Dunn’s (for b, c), depending on the distribution and homoscedasticity of data. p values <0.05 were
considered significant, with ∗ <0.05, ∗∗ <0.01, and ∗∗∗∗ <0.001 versus the control group, and ○ <0.05 and ○○ <0.01 versus the LPS 6 h group.
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products, but not oxidative stress, expressed as ratios of
either 2-OH-E+/DHE, E+/DHE, or 2-OH-E+/E+, as pro-
posed herein. Accordingly, our methodological approach
with the normalization of the 2-OH-E+ to the E+ content
in tissue demonstrated a distinct ROS environment in the
lung and liver after i.p. LPS.
Interestingly and in opposition to the nitrosative stress
systemically shown in the lung and liver, we demonstrated
decreased ∙NO production in the isolated aorta as early
as 6 hours after LPS challenge using EPR spin trapping
(Figure 3(a)). A decreased NO-Fe(DETC)2 signal is indicative
of endothelial dysfunction, as seen previously in other rodent
models [23, 42], and it is associated with lower NOS-3 activity
and altered NOS-3 phosphorylation, as reported previously
[43]. The development of peripheral endothelial dysfunction,
confirmed by decreased ∙NO release from the aorta, was coin-
cident with increased platelet activity evidenced by elevated
levels of platelet-derived TXB2 (a metabolite of TXA2) and
12-HETE during LPS-induced inflammation (Figure 5).
Although HPLC-based detection of DHE oxidation
products is one of the more specific methods of detection
of the intracellular steady-state superoxide activity, the
amount of 2-OH-E+ measured can only serve as a semi-
quantitative measure of superoxide concentration and com-
parison of absolute values between tissues and conclusions
must be made with caution, due to competing reactions with
superoxide dismutases, heme proteins, or other exogenous
compounds affecting DHE uptake and conversion in situ
to 2-OH-E+ [14]. On the other hand, DHE analysis in vivo
should not prohibit further mechanistically-oriented analy-
ses using for example Western blots; however, measuring
any other redox-dependent outcomes might obviously pro-
vide altered results, as DHE neutralizes superoxide. The
methodology described in this paper could be used in any
experimental model where one would want to study the
in vivo abundance of superoxide, especially in multiorgan
diseases or in the assessment of oxidant stress-targeted
therapeutic approaches. Moreover, this methodology could,
in principle, be targeted towards the detection of mitochon-
drial superoxide anions in vivo using MitoSOX, instead
of DHE.
Recently, a new NS-O two-photon fluorescent probe spe-
cific for the superoxide radical anion has been developed and
tested in living cells, tissues, and zebrafish [44], which might
develop in time as a better alternative to DHE oxidation
coupled with HPLC-based detection. Alternatively, immu-
nospin trapping [45] has emerged as an interesting method
to study the extent and localization of oxidative modifica-
tions in vivo and was used in acute endotoxemia [46, 47] as
well as in chronic inflammation [48] or in heart failure devel-
opment [49].
5. Conclusions
Our work demonstrates that intravenous injection of DHE
with consecutive HPLC analysis of its oxidation products
and calculation of 2-OH-E+/E+ ratios provide a means to
quantify and compare oxidative stress in multiple tissues
in vivo. This method overcomes the limitations of previous
studies assessing superoxide production in vivo without tak-
ing into account differences in the organ bioavailability of
DHE and not quantifying the concentrations of specific and
nonspecific DHE oxidation products in the organ, as we did
here. Results indicate a substantive increase in superoxide-
dependent oxidative stress in endotoxemia in the liver and
kidney with a moderate impact in the lung during endo-
toxemic injury induced by i.p. LPS challenge.
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